Clinical trial
Oxaliplatin and Topotecan in Advance Ovarian Cancer
NCT00313612 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00313612 |
|---|---|
| Title | Oxaliplatin and Topotecan in Advance Ovarian Cancer |
| Official title | A Phase II Study of Oxaliplatin Combined With Continuous Infusion Topotecan as Chemotherapy for Patients With Previously Treated Ovarian Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Ovarian Epithelial Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatin, topotecan |
| Enrollment | 39 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2011 |
| Completion | Dec 1, 2012 |
| First posted | Apr 12, 2006 |
| Last update posted | Nov 27, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: